| 000 | 01833 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515175550.0 | ||
| 264 | 0 | _c20100610 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1440-1681 | ||
| 024 | 7 |
_a10.1111/j.1440-1681.2009.05240.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, Jun | |
| 245 | 0 | 0 |
_aProtective effects of vasonatrin peptide against hypobaric hypoxia-induced pulmonary hypertension in rats. _h[electronic resource] |
| 260 |
_bClinical and experimental pharmacology & physiology _cJan 2010 |
||
| 300 |
_a69-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin II _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 | _aAtmospheric Pressure |
| 650 | 0 | 4 |
_aAtrial Natriuretic Factor _xblood |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEndothelin-1 _xblood |
| 650 | 0 | 4 |
_aHeart Ventricles _xdrug effects |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 |
_aHypertrophy, Right Ventricular _xdrug therapy |
| 650 | 0 | 4 | _aHypoxia |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Atrial Natriuretic Factor _xmetabolism |
| 700 | 1 | _aFeng, Hua-Song | |
| 700 | 1 | _aChen, Bao-Ying | |
| 700 | 1 | _aQu, Ping | |
| 700 | 1 | _aLiu, Li-Bing | |
| 700 | 1 | _aChen, Jian-Kang | |
| 700 | 1 | _aTie, Ru | |
| 700 | 1 | _aHuang, Xiao-Jun | |
| 700 | 1 | _aZhao, Yu-Feng | |
| 700 | 1 | _aZhu, Xiao-Xing | |
| 700 | 1 | _aZhu, Miao-Zhang | |
| 773 | 0 |
_tClinical and experimental pharmacology & physiology _gvol. 37 _gno. 1 _gp. 69-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1681.2009.05240.x _zAvailable from publisher's website |
| 999 |
_c18983609 _d18983609 |
||